Abstract:AIM:To study the antitumor effect of matrine in human hepatoma G2 (HepG2) cells and its molecular mechanism involved in antineoplastic activities.METHODS:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to detect viability of HepG2 cells. The effect of matrine on cell cycle was detected by fl ow cytometry. Annexin-V-FITC/PI double staining assay was used to detect cellular apoptosis. Cellular morphological changes were observed under an inverted phase contrast microscope. Transmission electron microscopy was performed to further examine ultrastructural structure of the cells treated with matrine. Monodansylcadaverine (MDC) staining was used to detect autophagy. Whether autophagy is blocked by 3-methyladenine (3-MA), an autophagy inhibitor, was evaluated. Expression levels of Bax and Beclin 1 in HepG2 cells were measured by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR).RESULTS:Matrine significantly inhibited the proliferation of HepG2 cells in a dose- and time-dependent manner, and induced G1-phase cell cycle arrest and apoptosis of HepG2 cells in a dose-dependent manner. The total apoptosis rate was 0.14% for HepG2 cells not treated with matrine. In contrast, the apoptosis rate was 28.91%, 34.36% and 38.80%, respectively, for HepG2 cells treated with matrine at the concentration of 0.5, 1.0 and 2.0 mg/mL. The remarkable morphological changes were observed under an inverted phase contrast microscope. Abundant cytoplasmic vacuoles with varying sizes were observed in HepG2 cells treated with matrine. Furthermore, vacuolization in cytoplasm progressively became larger and denser when the concentration of matrine was increased. Electron microscopy demonstrated formation of abundant autophagic vacuoles in HepG2 cells after matrine treatment. When the specific autophagic inhibitor, 3-MA, was applied, the number of autophagic vacuoles greatly decreased. MDC staining showed that the fluorescent density was higher and the number of MDC-labeled particles in HepG2 cells was greater in matrine treatment group than in control group. Fewer autophagic vacuoles were observed in the combined 3-MA and matrine treatment group when 3-MA was added before matrine treatment, indicating that both autophagy and apoptosis are activated when matrine-induced death of hepatoma G2 cells occurs. Real-time quantitative RT-PCR revealed that the expression levels of Bax gene, an apoptosis-related molecule, and Beclin 1 gene which plays a key role in autophagy were higher in matrine treatment group than in control group, indicating that Beclin 1 is involved in matrine-induced autophagy and the pro-apoptotic mechanism of matrine may be related to its upregulation of Bax expression.CONCLUSION:Matrine has potent antitumor activities in HepG2 cells and may be used as a novel effective reagent in treatment of hepatocellular carcinoma.

Matrine Inhibits Proliferation and Induces Apoptosis of Pancreatic Cancer Cells in Vitro and in Vivo.

Matrine Induces Caspase-Dependent Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Through the Upregulation of Bax and Fas/FasL and Downregulation of Bcl-2

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

Effects of Matrine on the Proliferation of HT29 Human Colon Cancer Cells and Its Antitumor Mechanism.

Matrine injection inhibits pancreatic cancer growth via modulating carbonic anhydrases- a network pharmacology-based study with in vitro validation

A Novel Matrine Derivate Inhibits Differentiated Human Hepatoma Cells and Hepatic Cancer Stem-Like Cells by Suppressing PI3K/AKT Signaling Pathways

Matrine Inhibits the Proliferation and Migration of Lung Cancer Cells Through Regulation of the Protein Kinase B/glycogen Synthase Kinase-3Β Signaling Pathways.

Matrine induces apoptosis in acute myeloid leukemia cells by inhibiting the PI3K/Akt/mTOR signaling pathway

Matrine Inhibits Proliferation and Induces Apoptosis of the Androgen‑independent Prostate Cancer Cell Line PC-3.

Matrine Induces the Apoptosis of Lung Cancer Cells Through Downregulation of Inhibitor of Apoptosis Proteins and the Akt Signaling Pathway

[Inhibition of invasiveness and expression of heparanase-mRNA in human malignant melanoma cell line A375 by matrine].

Matrine Inhibits Proliferation and Induces Apoptosis Via BID-mediated Mitochondrial Pathway in Esophageal Cancer Cells

Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-κB signaling

Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway.

Matrine Induces Apoptosis in Gastric Carcinoma Cells Via Alteration of Fas/FasL and Activation of Caspase-3

Antitumor Effect of Matrine in Human Hepatoma G2 Cells by Inducing Apoptosis and Autophagy.

Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing Mirna Expression Profiles

Chinese Herb Medicine Matrine Induce Apoptosis in Human Esophageal Squamous Cancer KYSE-150 Cells Through Increasing Reactive Oxygen Species and Inhibiting Mitochondrial Function.

Matrine Inhibits the Progression of Prostate Cancer by Promoting Expression of GADD45B.